Articles

Breast Cancer

View All
Close-up of a healthcare professional holding a HER2-targeted therapy medication, emphasizing advancements in HER2-directed treatment.

Breast Cancer

07/23/2026

Trastuzumab Deruxtecan and the Evolution of HER2-Directed Therapy

Jasmin Hundal, MD

General News

View All
Oncology Brothers moderating third annual Upstate Cancer Symposium for community clinical practice, focusing on latest oncology research and patient care.

General News

05/05/2026

Oncology Brothers to Moderate Third Annual Upstate Cancer Symposium for Community Clinical Practice

Kaylee Giacomini, MPH
SignifyMD partners with leading oncology voices to host two live events during ASCO annual meeting, highlighting advancements in cancer care and oncology research.

General News

05/01/2026

SignifyMD Partners With Leading Oncology Voices to Host Two Live Events During ASCO Annual Meeting

Kaylee Giacomini, MPH

GI Oncology

View All
A medication bottle with a red cap on a pharmacy counter, blurred pharmacy shelves in the background.

GI Oncology

10/21/2025

Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

Sawyer Bawek, DO

GU Oncology

View All
Medical illustration showing cancer cells and immune response, emphasizing post-IO strategy in metastatic renal cell carcinoma (mRCC) and the role of TKI therapy timing.

GU Oncology

05/27/2026

Refining the Post-IO Strategy in mRCC: The Role of TKIs and the Nuance of Timing

Karan Jatwani, MDUrvi Patel, DO, MPH
Medical professional holding a stethoscope, focusing on the evolving landscape of refractory renal cell carcinoma in cancer treatment.

GU Oncology

05/14/2026

The Evolving Landscape of Refractory Renal Cell Carcinoma 

Michael Serzan, MD
Overview of targeted therapies following immunotherapy in metastatic renal cell carcinoma, highlighting treatment strategies and clinical insights.

GU Oncology

05/13/2026

TKIs After Upfront Immunotherapy in Metastatic RCC: A Practical Review

Brendan Guercio, MD

Hematology

View All
Healthcare professional holding a tray of blood samples at ISTH 2026 conference on cancer-associated thrombosis.

Hematology

07/30/2026

ISTH 2026: Key Takeaways in Cancer-Associated Thrombosis and Thrombocytopenia 

William Archibald, MDKevin Zablonski, MD
Microscopic view of blood cells showing leukemia, highlighting Ziftomenib Plus induction for AML treatment.

Hematology

06/24/2026

EHA 2026: Ziftomenib Plus Intensive Induction Shows Deep Durable Responses in Newly Diagnosed NPM1-Mutant or KMT2A-Rearranged AML

Sawyer Bawek, DO
Teclistamab monotherapy shown as a promising treatment for multiple myeloma, highlighting survival benefits in early relapsed or refractory cases.

Hematology

05/27/2026

MajesTEC-9: Teclistamab Monotherapy Delivers Survival Benefits in Early Relapsed/Refractory Multiple Myeloma

Sawyer Bawek, DO
Immune cells attacking cancer cells, cancer immunotherapy, tumor microenvironment, oncology research, blood vessel interaction, cancer treatment strategies, immunology, medical imaging for cancer diagnostics.

Hematology

12/26/2025

Year in Review: The Rise of Cellular Immunotherapy for Multiple Myeloma

Hamza Hashmi, MD
Immune cells attacking cancer cells in the bloodstream, illustrating cancer immunotherapy and blood cancer treatment strategies.

Hematology

10/09/2025

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

Sawyer Bawek, DO
Uncancerous blood cells and white blood cells circulating in a blood vessel for medical research and oncology updates.

Hematology

08/15/2025

The Impact of Novel Agents in Non-Hodgkin Lymphoma Treatment

Anuja V. Abhyankar, MD
Malignant cell division illustration showing cancer cells attacking the human immune system and bloodstream, emphasizing oncology research and targeted cancer therapies.

Hematology

07/28/2025

Management of Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory Disease

Vaishali Deenadayalan, MD

Lung Cancer

View All
Medical professional performing a laboratory test related to NSCLC treatment research, highlighting advanced oncology diagnostics and targeted therapies.

Lung Cancer

05/18/2026

Beyond Osimertinib Monotherapy: Frontline Intensification in EGFR-Mutant NSCLC After FLAURA2 and MARIPOSA

Chinmay Jani, MDRuchi JaniGilberto Lopes, MD
1. Doctor explaining lung cancer scan results to patient with lung model and medical images on computer screen, in a clinical setting.

Lung Cancer

01/25/2026

Top Lung Cancer Advances From 2025

Chinmay Jani, MDAli Al Sbihi, MDGilberto Lopes, MD
Chest X-ray showing lung cancer, medical diagnosis, healthcare, oncology scan, doctor reviewing cancer imaging.

Lung Cancer

11/18/2025

Ivonescimab Plus Chemotherapy in EGFR+ NSCLC After TKI Therapy

Ali Al Sbihi, MDChinmay Jani, MD
Detailed 3D rendering of human lungs showing the bronchial tubes, arteries, and veins for educational medical or respiratory health content.

Lung Cancer

05/28/2025

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sawyer Bawek, DO
Lung cancer illustration showing tumor growth inside the lung with detailed respiratory system anatomy.

Lung Cancer

05/26/2025

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Sawyer Bawek, DO